VolitionRx Limited announced the appointment of Mickie Henshall to its board of directors effective August 15, 2022.  Ms. Henshall was also appointed as a member of the Compensation Committee and the Nominations and Governance Committee. Mickie is a seasoned marketing executive with over 20 years of experience in developing and implementing marketing and sales strategies within the IVD, clinical, and life science industries. Early on in her career, Ms. Henshall served as Associate Director of Diagnostics Marketing at Illumina Inc. and has subsequently led global marketing operations at Biotix Inc., Accriva Diagnostics Inc. (acquired by Werfen Life), Agena Bioscience Inc., and WGA (Genomic Life Inc.).

Mickie is currently Chief Marketing Officer at REALM IDx Inc., a pioneering integrated diagnostics company.